You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR DETROL LA

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DETROL LA

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00143481 ↗	Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women	Completed	Pfizer	Phase 4	2005-03-01	The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
NCT00143481 ↗	Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2005-03-01	The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.
NCT00147654 ↗	Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction	Completed	Pfizer	Phase 4	2004-11-01	The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
NCT00147654 ↗	Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2004-11-01	The primary objective of the trial is to evaluate the effect of tolterodine ER plus tamsulosin versus placebo on patient perception of overall treatment benefit in men who have frequency and urgency, with or without urinary urge incontinence (UUI), with or without bladder outlet obstruction (BOO).
NCT00174798 ↗	MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.	Completed	Sanofi	Phase 2	2005-05-01	To evaluate the safety and efficacy of SSR240600C versus placebo on clinical and cystometric parameters in patients with OAB and UUI.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DETROL LA

Condition Name

Chart
Table

Condition Name for DETROL LA
Intervention	Trials
Urinary Incontinence	5
Overactive Bladder	4
Overactive Bladder (OAB)	2
Urinary Bladder, Overactive	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DETROL LA
Intervention	Trials
Urinary Bladder, Overactive	11
Enuresis	7
Urinary Incontinence	7
Urinary Incontinence, Urge	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DETROL LA

Trials by Country

Map
Table

Trials by Country for DETROL LA
Location	Trials
United States	186
Canada	11
United Kingdom	4
South Africa	4
Spain	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DETROL LA
Location	Trials
California	10
New York	9
Florida	8
Arizona	8
Texas	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DETROL LA

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DETROL LA
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	3
Phase 2	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DETROL LA
Clinical Trial Phase	Trials
Completed	15
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DETROL LA

Sponsor Name

Chart
Table

Sponsor Name for DETROL LA
Sponsor	Trials
Pfizer	8
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	5
Astellas Pharma Inc	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DETROL LA
Sponsor	Trials
Industry	20
Other	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.